Showing 421 - 440 results of 9,782 for search '"therapeutics"', query time: 0.06s Refine Results
  1. 421
  2. 422
  3. 423

    A Case of the Serotonin Syndrome Secondary to Phenelzine Monotherapy at Therapeutic Dosing by A. Malik, N. Junglee

    Published 2015-01-01
    “…To the best of our knowledge, this is the first reported case to associate the condition with phenelzine alone at therapeutic dose.…”
    Get full text
    Article
  4. 424
  5. 425

    Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation by Audrey Ortega-Ramírez, Rosario Vega, Enrique Soto

    Published 2017-01-01
    “…Over the years, different studies have shown that activation of these channels is linked to various physiological and pathological processes, such as memory, learning, fear, anxiety, ischemia, and multiple sclerosis to name a few, so their potential as therapeutic targets is increasing. This review focuses on recent advances that have helped us to better understand the role played by ASICs in different pathologies related to neurodegenerative diseases, inflammatory processes, and pain.…”
    Get full text
    Article
  6. 426

    Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles by Yuqi Song, Fengrui Liang, Weikun Tian, Erin Rayhill, Liping Ye, Xinghan Tian

    Published 2025-02-01
    “…Mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles (MSC-EVs) are increasingly recognized for their therapeutic potential in regenerative medicine, driven by their capabilities in immunomodulation and tissue repair. …”
    Get full text
    Article
  7. 427

    Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells by Ahmad Hamad, Zeyad Sahli, Maya El Sabban, Maha Mouteirik, Rihab Nasr

    Published 2013-01-01
    “…This highlights the need to develop new therapeutic strategies for CML to achieve a permanent cure, and to allow TKI interruption. …”
    Get full text
    Article
  8. 428

    Therapeutic target genes and regulatory networks of gallic acid in cervical cancer by Zhixi You, Ye Lei, Yongkang Yang, Zhihui Zhou, Xu Chao, Keyi Ju, Songyi Wang, Yuanyuan Li, Yuanyuan Li

    Published 2025-01-01
    “…IntroductionThis study aims to identify the therapeutic targets and regulatory mechanisms of the antitumor drug gallic acid (GA) in cervical cancer (CC).MethodsHeLa cells were treated with GA and subjected to RNA-sequencing using the DNBSEQ platform. …”
    Get full text
    Article
  9. 429
  10. 430
  11. 431

    Classifications of triple-negative breast cancer: insights and current therapeutic approaches by Ziqi Chen, Yumeng Liu, Minchuan Lyu, Chi Ho Chan, Meiheng Sun, Xin Yang, Shuangying Qiao, Zheng Chen, Sifan Yu, Meishen Ren, Aiping Lu, Ge Zhang, Fangfei Li, Yuanyuan Yu

    Published 2025-02-01
    “…We also address the limitations of conventional therapeutic approaches and explore innovative biological strategies, all aimed at advancing the development of targeted and effective therapeutic strategies for TNBC.…”
    Get full text
    Article
  12. 432

    Therapeutic potential of 4-hexylresorcinol in reducing sarcopenia in diabetic masseter muscle by Dhouha Gaida, Young-Wook Park, Yei-Jin Kang, Seong-Gon Kim

    Published 2025-01-01
    “…These findings suggest that 4HR holds potential as a therapeutic agent for combating muscle wasting in diabetes.…”
    Get full text
    Article
  13. 433

    Grave’s Disease with Severe Hepatic Dysfunction: A Diagnostic and Therapeutic Challenge by Ashok Krishna Bhuyan, Dipti Sarma, Uma Kaimal Saikia, Bipul Kumar Choudhury

    Published 2014-01-01
    “…Hepatic dysfunction in a patient with thyrotoxicosis may result from hyperthyroidism per se, as a side effect of antithyroid drugs, and causes unrelated to hyperthyroidism which sometimes causes diagnostic and therapeutic difficulties. A young female patient was admitted to our hospital with symptoms of thyrotoxicosis, diffuse goiter and ophthalmopathy along with cholestatic pattern of jaundice, and proximal muscle weakness. …”
    Get full text
    Article
  14. 434

    Neratinib as a Potential Therapeutic for Mutant RAS and Osimertinib-Resistant Tumours by Paul Dent, Laurence Booth, Andrew Poklepovic, John F. Hancock

    Published 2022-09-01
    “…Collectively, these findings argue that the possibilities for the further development of neratinib as cancer therapeutic in malignancies that do not express or over-express members of the ERBB receptor family are potentially wide-ranging.…”
    Get full text
    Article
  15. 435

    Chitosan Micro/Nanocapsules in Action: Linking Design, Production, and Therapeutic Application by Yaride Pérez-Pacheco, Bartosz Tylkowski, Ricard García-Valls

    Published 2025-01-01
    “…The potential to customize chitosan for different environments and therapeutic uses introduces opportunities for drug encapsulation and release. …”
    Get full text
    Article
  16. 436

    Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response by Jérémie Sellam, Claire I Daien

    Published 2015-06-01
    “…This article first reviews the epidemiological and clinical data available on obesity in inflammatory rheumatic diseases, that is, its impact on incident disease, disease characteristics and the therapeutic response. The second part of this review gives an overview of the factors potentially involved in the specifics of inflammatory arthritis in patients with obesity, such as limitations in the clinical assessment, diet, microbiota and adipokines.…”
    Get full text
    Article
  17. 437
  18. 438

    Regulation of Posttranscriptional Modification as a Possible Therapeutic Approach for Retinal Neuroprotection by Yoko Ozawa, Toshihide Kurihara, Kazuo Tsubota, Hideyuki Okano

    Published 2011-01-01
    “…Finally, we review the therapeutic potential of regulating the UPS to protect tissue function, citing examples from clinical applications in other medical fields.…”
    Get full text
    Article
  19. 439

    The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity by Hui Li, Fang Wang, Mu Yang, Jiao Sun, Yi Zhao, Dongqi Tang

    Published 2021-01-01
    “…Irisin, a newly identified exercise-responsive myokine, which is produced by the proteolytic cleavage of fibronectin type III domain-containing protein 5 (FNDC5), has emerged as a promising therapeutic strategy to combat obesity and obesity-related complications. …”
    Get full text
    Article
  20. 440

    Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo by Linli Liu, Lingli Deng, Li Guan, Yuan Hu, Qianying Li, Chunshui Yu

    Published 2025-01-01
    “…Collectively, our findings provide novel insights into the molecular mechanisms underpinning vitiligo and suggest new avenues for diagnostic and therapeutic development.…”
    Get full text
    Article